These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11764660)

  • 1. How the game is played--challenge between therapeutic benefit and acute toxicity in fractionated radiotherapy.
    Maciejewski B; Miszczyk L; Tarnawski R; Składowski K
    Front Radiat Ther Oncol; 2002; 37():174-84. PubMed ID: 11764660
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute oropharyngeal effects of full-course radiation treatment of tumors of the head.
    Collen EB; Mayer MN
    Can Vet J; 2008 May; 49(5):509-12. PubMed ID: 18512465
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.
    Fowler JF; Harari PM; Leborgne F; Leborgne JH
    Radiother Oncol; 2003 Nov; 69(2):161-8. PubMed ID: 14643953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy in head and neck cancer.
    Alfouzan AF
    Saudi Med J; 2021 Mar; 42(3):247-254. PubMed ID: 33632902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Marcu LG
    Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy oncology: in regard to Fu et al., IJROBP 2000;48:7-16.
    Logie MB
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148. PubMed ID: 11958925
    [No Abstract]   [Full Text] [Related]  

  • 7. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
    Bentzen SM; Saunders MI; Dische S
    Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered fractionation: limited by mucosal reactions?
    Kaanders JH; van der Kogel AJ; Ang KK
    Radiother Oncol; 1999 Mar; 50(3):247-60. PubMed ID: 10392810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based organ-sparing radiotherapy in head and neck cancer.
    Dirix P; Nuyts S
    Lancet Oncol; 2010 Jan; 11(1):85-91. PubMed ID: 20129131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
    Bartelink H; Van den Bogaert W; Horiot JC; Jager J; van Glabbeke M
    Eur J Cancer; 2002 Mar; 38(5):667-73. PubMed ID: 11916549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered radiotherapy fractionation: an opportunity not to be missed.
    Benson RJ; Burnet NG
    Clin Oncol (R Coll Radiol); 1998; 10(3):150-4. PubMed ID: 9704175
    [No Abstract]   [Full Text] [Related]  

  • 13. Accelerated fractionation (AF) in head and neck cancers.
    Jones B; Dale RG
    Radiother Oncol; 1998 Apr; 47(1):107-8. PubMed ID: 9632304
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic overview of radiation therapy effects in head and neck cancer.
    Zackrisson B; Mercke C; Strander H; Wennerberg J; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):443-61. PubMed ID: 14596506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation tolerance of the cervical spinal cord.
    Kim YH; Fayos JV
    Radiology; 1981 May; 139(2):473-8. PubMed ID: 7220892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caution on the use of altered fractionation for nasopharyngeal carcinoma.
    Lee AW; Sze WM; Fowler JF; Chappell R; Leung SF; Teo P
    Radiother Oncol; 1999 Sep; 52(3):207-11. PubMed ID: 10580865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In response to Drs. Dubben, Beck-Bornholdt, and Llogie.
    Ang KK; Berkey BA; Pajak TF; Fu KK
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148-50. PubMed ID: 11958923
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-volume tolerance of the brainstem after high-dose radiotherapy.
    Debus J; Hug EB; Liebsch NJ; O'Farrel D; Finkelstein D; Efird J; Munzenrider JE
    Front Radiat Ther Oncol; 1999; 33():305-14. PubMed ID: 10549500
    [No Abstract]   [Full Text] [Related]  

  • 19. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas.
    De Crevoisier R; Bourhis J; Eschwège F
    Cancer Treat Res; 2003; 114():199-212. PubMed ID: 12619542
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing treatment side effects for head and neck cancer.
    Br Dent J; 2005 Nov; 199(9):555. PubMed ID: 16288244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.